Search results
- Michael A. Frohman, MD, PhD Distinguished Professor and Chair, Pharmacological Sciences, Renaissance School of Medicine at Stony Brook University
People also ask
Who is Dr. Frohman?
Who is John Frohman?
Who is Larry Frohman?
Who is Chris Frohman?
Where does David Frohman live now?
Is the Frohman laboratory cloning lipid-signaling Phospholipase D genes?
Michael. A. Frohman. MD,PhD. Distinguished Professor and Chair. Director, Medical Scientist Training Program. Fellow of the American Association for the Advancement of Science (AAAS) Association of American Physicians (AAP) Postdoctoral fellowship, University of California at San Francisco.
Sep 23, 2021 · Michael Frohman, distinguished professor and chair of Pharmacological Sciences in the Renaissance School of Medicine, has been named a 2021 American Society for Pharmacology and Experimental Therapeutics (ASPET) Fellow, an achievement given to its most distinguished members.
2009. Articles 1–20. Distinguished Professor and Chair of Pharmacology, Stony Brook University - Cited by 31,847 - lipid signaling.
Lipid Signaling and Metabolism in Cancer. Department. Pharmacological Sciences. Research Interest. The Frohman laboratory cloned and has been exploring translational roles for the mammalian family of lipid-signaling Phospholipase D genes for the two decades.
Apr 1, 2021 · Frohman, Chair of the Department of Pharmacological Sciences in the Renaissance School of Medicine at SBU, has worked with the gene Phospholipidase D1 (or PLD1), for over 25 years. Researchers including Najim Lahrouchi and Connie Bezzina at the University of Amsterdam Heart Center linked this gene to congenital heart disease.
Distinguished Professor Michael Frohman has directed the MSTP for the past 20+ years. Dr. Frohman graduated from the U. Pennsylvania MSTP in 1985 with an MD and a PhD in Immunology, was a postdoctoral fellow at UCSF, and joined the Pharmacology Dept. at SBU in 1992.
Nov 6, 2012 · Michael Frohman’s group has investigated the role of a lipid signaling enzyme in tumor angiogenesis and metastasis. The enzyme is phospholipase D1—or PLD1—and its activity has been linked to cancer growth and progression. Frohman spoke to me from Stony Brook University.
